# PALVELLA THERAPEUTICS, INC. (PVLA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from PALVELLA THERAPEUTICS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/PVLA/mda/fy2025/): filed 2026-03-31; accession 0001193125-26-133372 (https://www.sec.gov/Archives/edgar/data/1583648/000119312526133372/pvla-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/PVLA/mda/fy2024/): filed 2025-03-31; accession 0000950170-25-047212 (https://www.sec.gov/Archives/edgar/data/1583648/000095017025047212/pvla-20241231.htm)
- [FY 2023 MD&A](/company/PVLA/mda/fy2023/): filed 2024-03-29; accession 0001437749-24-010123 (https://www.sec.gov/Archives/edgar/data/1583648/000143774924010123/pirs20231231_10k.htm)
- [FY 2022 MD&A](/company/PVLA/mda/fy2022/): filed 2023-03-31; accession 0001437749-23-008834 (https://www.sec.gov/Archives/edgar/data/1583648/000143774923008834/pirs20221231_10k.htm)
- [FY 2021 MD&A](/company/PVLA/mda/fy2021/): filed 2022-03-02; accession 0001583648-22-000016 (https://www.sec.gov/Archives/edgar/data/1583648/000158364822000016/pirs-20211231.htm)

Back to /company/PVLA/